Infection, cancer and prevention: report of the 19th International Symposium of the Foundation for Promotion of Cancer Research.

Professor Takashi Sugimura (National Cancer Center, Tokyo) opened the symposium with a welcome address and a review of previous symposia (1,2). The Foundation for Promotion of Cancer Research has held this International Symposium annually since 1987, as one of the activities of the first 10-year strategy for its cancer control program, and has continued through the second and third terms of the strategy. From the first to the 18th symposium, the total number of invited speakers was 578: 307 from Japan, 183 from the USA, 17 from the UK, 14 from France and 57 from 17 other nations. For this year’s symposium, the Foundation invited 10 speakers from abroad and 24 from Japan (Fig. 1). Professor Sugimura stated his personal interest in this year’s topic and emphasized that the content of the program was divided into three main topics: infectious route, cancer mechanism and prevention. Next, the international chairman Professor Martin Blaser (New York University) after welcoming all attendees summarized the microbes implicated in the causation of human cancers. During his talk, Professor Blazer reported that cancers could be due to the loss of indigenous microbes, and summarized the mechanisms by which their loss could enhance disease risk: direct effects on host cell physiology, loss of suppression of other endogenous organisms and ease of colonization by acquired organisms.

[1]  M. Hatakeyama Oncogenic mechanisms of the Helicobacter pylori CagA protein , 2004, Nature Reviews Cancer.

[2]  S. Kamiya,et al.  Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice. , 2000, Journal of medical microbiology.

[3]  T. Liang,et al.  Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Hakama,et al.  Report of the Thirteenth International Symposium of the Foundation for Promotion of Cancer Research: cancer screening-past, present and future. , 2000, Japanese journal of clinical oncology.

[5]  M Fujita,et al.  Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Blaser,et al.  Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.

[7]  K. Takada,et al.  Phosphatidylinositol 3-Kinase Is a Determinant of Responsiveness to B Cell Antigen Receptor-Mediated Epstein-Barr Virus Activation1 , 2004, The Journal of Immunology.

[8]  M. Blaser,et al.  Helicobacter pylori persistence: biology and disease. , 2004, The Journal of clinical investigation.

[9]  R. Jacobson,et al.  Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. , 2004, The New England journal of medicine.

[10]  T. Kanda,et al.  Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation , 2005, Journal of Virology.

[11]  M. Alter,et al.  Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.

[12]  T. Sugiyama,et al.  Melanoidin, a Food Protein‐Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo , 2004, Helicobacter.

[13]  M. Alter,et al.  Epidemiology of hepatitis B in Europe and worldwide. , 2003, Journal of hepatology.

[14]  M. V. Doeberitz New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. , 2002 .

[15]  M. Blaser,et al.  Dynamics of Helicobacter pylori colonization in relation to the host response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Martin J Blaser,et al.  Bacterial biota in the human distal esophagus , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Jacobson,et al.  Prevention of Hepatitis B with the Hepatitis B Vaccine , 2004 .

[18]  H. Maeda,et al.  Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH. , 1999, Cancer letters.

[19]  J. Lee,et al.  Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.